Invention Grant
- Patent Title: Kappa-opiate agonists for the treatment of diarrhea-predominant irritable bowel syndrome
- Patent Title (中): 卡帕阿片激动剂用于治疗腹泻型肠易激综合征
-
Application No.: US12940979Application Date: 2010-11-05
-
Publication No.: US08877800B2Publication Date: 2014-11-04
- Inventor: Allen Mangel
- Applicant: Allen Mangel
- Applicant Address: US CA San Diego
- Assignee: Tioga Pharmaceuticals, Inc.
- Current Assignee: Tioga Pharmaceuticals, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Morrison & Foerster LLP
- Main IPC: A61K31/40
- IPC: A61K31/40
Abstract:
The present invention concerns methods useful in treating a subject having diarrhea-predominant IBS (IBS-D) by administering N-methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamide and/or a pharmaceutically acceptable salt thereof to the subject.
Public/Granted literature
- US20110046174A1 KAPPA-OPIATE AGONISTS FOR THE TREATMENT OF DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME Public/Granted day:2011-02-24
Information query
